Indoco Remedies Q3 FY24 Results Live : profit falls by 42.08% YOY
Indoco Remedies Q3 FY24 Results Live : Revenue increased by 15.09% YoY & profit decreased by 42.08% YoY
Indoco Remedies declared their Q3 FY24 results on 23 Jan, 2024. The topline increased by 15.09% & the profit decreased by 42.08% YoY. As compared to the previous quarter the revenue declined by 4.63% and the profit decreased by 53.53%.
The Selling, general & administrative expenses declined by 2.33% q-o-q & increased by 9.55% Y-o-Y.
The operating income was down by 39.25% q-o-q & decreased by 32.36% Y-o-Y.
The EPS is ₹2.27 for Q3 FY24 which decreased by 25.42% Y-o-Y.
Indoco Remedies has delivered -5.47% return in the last 1 week, 14.22% return in last 6 months and -6.69% YTD return.
Currently the Indoco Remedies has a market cap of ₹3398.04 Cr and 52wk high/low of ₹415 & ₹306.4 respectively.
As of 25 Jan, 2024 out of 5 analysts covering the company, 2 analysts have given Hold rating, 1 analyst has given Buy rating & 2 analysts have given Strong Buy rating.
The consensus recommendation as on 25 Jan, 2024 was to Buy.
Indoco Remedies Financials
| Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 459.42 | 481.73 | -4.63% | 399.2 | +15.09% |
| Selling/ General/ Admin Expenses Total | 89.97 | 92.12 | -2.33% | 82.13 | +9.55% |
| Depreciation/ Amortization | 24.35 | 21.41 | +13.73% | 17.17 | +41.82% |
| Total Operating Expense | 429.07 | 431.77 | -0.63% | 354.33 | +21.09% |
| Operating Income | 30.35 | 49.96 | -39.25% | 44.87 | -32.36% |
| Net Income Before Taxes | 22.63 | 46.28 | -51.1% | 38.22 | -40.79% |
| Net Income | 16.3 | 35.08 | -53.53% | 28.14 | -42.08% |
| Diluted Normalized EPS | 2.27 | 3.82 | -40.46% | 3.05 | -25.42% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.